Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00453661 · ClinicalTrials.gov registry record
Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities
A clinical trial of Breast Cancer and Prostate Cancer, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 2,472
- Enrollment target
- 1
- Study location
NCT00453661: Completed study of Breast Cancer and Prostate Cancer, sponsored by M.D. Anderson Cancer Center.
NCT00453661 is a study of Breast Cancer and Prostate Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 2,472 participants, below the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (12% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00453661, a study of Breast Cancer and Prostate Cancer, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 2,472 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this behavioral research study is to improve the use of cancer prevention services, increase early detection, and treatment of cancer. A secondary outcome of this demonstration project proposes that a structured patient navigator (PN) will reduce the cost of Medicare services.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaire
- BEHAVIORAL Patient Navigator (PN)
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,472 participants |
| Start Date | 2007-03 |
| Est. Completion | 2020-09-28 |
What the finished NCT00453661 record still lists
NCT00453661 is an observational study that tracks outcomes without assigning an intervention. Its 2,472 participants enrollment target places it among the larger protocols in the corpus, below the 2,801-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (12% lower).
The record links to 5 conditions, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire is the first listed.
NCT00453661 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00453661 about?
NCT00453661 is a clinical study titled "Cancer Prevention and Treatment Demonstration for Ethnic and Racial Minorities". The goal of this behavioral research study is to improve the use of cancer prevention services, increase early detection, and treatment of cancer. A secondary outcome of this demonstration project proposes that a structured patient navigator (PN) will reduce the cost of Medicare services.
What is the current status of trial NCT00453661?
This trial is currently completed. The enrollment target is 2,472 participants. The study started on 2007-03. Estimated completion is 2020-09-28.
What conditions does trial NCT00453661 study?
This clinical trial studies the following conditions: Breast Cancer, Prostate Cancer, Lung Cancer, Colorectal Cancer, Cervical Cancer.
What interventions are being tested in trial NCT00453661?
The interventions under investigation include: Questionnaire (BEHAVIORAL), Patient Navigator (PN) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00453661?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00453661 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00453661's enrollment target sits among peer trials
2,472 59th of 1224 higher than 1,166 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06898593 · 2,448 participants · NA
Enhancing Engagement by Integrating Goals and Concerns That Matter to Patients
- NCT00001160 · 2,500 participants
Studies on Tumors of the Thyroid
- NCT01904188 · 2,500 participants
Clinical Microbial Species & Antibiotic Resistance ID in ED Patients Presenting With Infection - is Rapid ID Possible & Accurate?
- NCT02257229 · 2,500 participants
Prospective Evaluation of Treatment for Clubfoot
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia